Mitoxantrone treatment of murine myeloid
โ
Aminu A. Abubakar; Andrew C. Riches
๐
Article
๐
1995
๐
John Wiley and Sons
๐
French
โ 569 KB
The low-cell-dose (LD) and the high-cell-dose (HD) transplant variants of the SA7 murine rnyeloid leukaemia cell line have different growth characteristics and clinical presentations. In addition, the low-cell-dose transplant subline (SA7LD) was more responsive than the high-cell-dose variant (SA7HD